Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis-Reference-Cited by-同舟云学术

Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis

Published:2020-07 Issue:7 Volume:109 Page:2145-2155
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Hosny Khaled M.,Bahmdan Rahaf H.,Alhakamy Nabil A.,Alfaleh Mohamed A.,Ahmed Osama A.,Elkomy Mohammed H.

Funder

Deanship of Scientific Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Primary osteoporosis in postmenopausal women;Ji;Maturitas,2015

2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women;Kanis;Osteoporos Int,2013

3. American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016;Camacho;Endocr Pract,2016

4. UK clinical guideline for the prevention and treatment of osteoporosis;Compston;Arch Osteoporos,2017

5. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology;Tarantino;J Orthop Traumatol,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone targeted nano-drug and nano-delivery;Bone Research;2024-09-04

2. Antiproliferative activity of syringic acid-loaded nanostructured lipid carriers against MCF-7 human breast carcinoma cells;Journal of Drug Delivery Science and Technology;2024-09

3. Bone Targeting Nanoparticles for the Treatment of Osteoporosis;International Journal of Nanomedicine;2024-02

4. Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice;Pharmaceutical Research;2024-02-01

5. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies;Drug Delivery and Translational Research;2023-09-28